NEW YORK (AP) _ Actinium Pharmaceuticals Inc. (ATNM) on Friday reported a loss of $5.3 million in its first quarter.
The New York-based company said it had a loss of 29 cents per share.
The cancer drug developer posted revenue of $622,000 in the period.
Actinium shares have dropped 9% since the beginning of the year. In the final minutes of trading on Friday, shares hit $7.09, an increase of 31% in the last 12 months.
The Associated Press